These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 27434824

  • 1. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C, Ginanni Corradini S, Abraldes JG, Merli M, Tandon P, Ferri F, Parlati L, Lattanzi B, Poli E, Di Gregorio V, Farcomeni A, Riggio O.
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [Abstract] [Full Text] [Related]

  • 2. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 3. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A.
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [Abstract] [Full Text] [Related]

  • 4. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ, Gish RG, Ahmed A.
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [Abstract] [Full Text] [Related]

  • 5. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L.
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [Abstract] [Full Text] [Related]

  • 6. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR, Ferguson N, Cannon RM, Jones CM, Brock GN.
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [Abstract] [Full Text] [Related]

  • 7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 8. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC, Liver Transplantation Group.
    Clin Transplant; 2012 Sep; 26(4):E395-401. PubMed ID: 22882694
    [Abstract] [Full Text] [Related]

  • 9. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K, Aguilar M, Gish R, Younossi Z, Saab S, Bhuket T, Liu B, Ahmed A, Wong RJ.
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [Abstract] [Full Text] [Related]

  • 10. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
    Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC.
    Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053
    [Abstract] [Full Text] [Related]

  • 11. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP, Tandon P, Ney M, Meeberg G, Faris P, Shaheen AA, Aspinall AI, Burak KW.
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [Abstract] [Full Text] [Related]

  • 12. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA, Lundgren JD, Hillingsø J, Peters L, Mocroft A, Rasmussen A.
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [Abstract] [Full Text] [Related]

  • 13. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
    Hu XP, Gao J.
    World J Gastroenterol; 2019 Jul 14; 25(26):3426-3437. PubMed ID: 31341366
    [Abstract] [Full Text] [Related]

  • 14. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG, de Medeiros Fleck A, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.
    Ann Hepatol; 2013 Jul 14; 12(3):440-7. PubMed ID: 23619261
    [Abstract] [Full Text] [Related]

  • 15. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N, Nourijelyani K, Nasiri-Tousi M, Ghodssi-Ghassemabadi R, Azmoudeh-Ardalan F, Nedjat S.
    Arch Iran Med; 2014 Feb 14; 17(2):118-21. PubMed ID: 24527973
    [Abstract] [Full Text] [Related]

  • 16. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM.
    J Hepatol; 2018 Apr 14; 68(4):707-714. PubMed ID: 29221886
    [Abstract] [Full Text] [Related]

  • 17. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J, Simón M, Montoliú C, Jover R, Serra MÁ, Córdoba J, Romero-Gómez M.
    Gastroenterology; 2015 Nov 14; 149(6):1483-9. PubMed ID: 26299413
    [Abstract] [Full Text] [Related]

  • 18. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
    Bernardi M, Gitto S, Biselli M.
    J Hepatol; 2011 Jun 14; 54(6):1297-306. PubMed ID: 21145851
    [Abstract] [Full Text] [Related]

  • 19. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar 14; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 20. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.
    Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA.
    Liver Int; 2012 Jan 14; 32(1):158-64. PubMed ID: 22098119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.